Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) dropped 11.1% during trading on Tuesday . The stock traded as low as GBX 2 and last traded at GBX 2. Approximately 75,237 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 947,546 shares. The stock had previously closed at GBX 2.25.
Cizzle Biotechnology Trading Down 11.1%
The stock has a 50 day moving average of GBX 1.64 and a 200-day moving average of GBX 1.60. The company has a market capitalization of £7.93 million, a P/E ratio of -6.25 and a beta of 0.51. The company has a current ratio of 0.48, a quick ratio of 4.66 and a debt-to-equity ratio of -54.35.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Articles
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
